Clinical Research Award
Alzheimer's Research UK's Clinical Research Award funds innovative clinical studies and early-phase trials to accelerate new dementia therapies.
Funder: Alzheimer's Research UK
Due Dates: Rolling (EOI) | February & July (Full application outcomes)
Funding Amounts: Flexible; no fixed minimum or maximum. Project duration and budget tailored to proposal needs.
Summary: Supports ambitious, investigator-led clinical and experimental medicine studies advancing dementia therapies and early-phase clinical trials.
Key Information: Lead applicant must be UK-based; international and industry partners are encouraged as co-investigators or collaborators.
Description
The Clinical Research Award from Alzheimer's Research UK aims to accelerate the development of new dementia therapies by supporting high-quality, investigator-led clinical research. This scheme is a core part of the charity’s Clinical Accelerator Programme, designed to foster innovative experimental medicine studies, early-phase clinical trials (typically phase 1b/2a), and added-value sub-studies that bridge biological investigation with clinical intervention. The award encourages collaborative, multidisciplinary research that integrates biomarker advances, supports data sharing, and strengthens the clinical trial pipeline for dementia.
